000			01764cam a22003014a 4500
008			020815s2002 dcu grb i000 0 eng
020			_a0821352121
040			_aDLC _cDLC
050	0	0	_aHD9672.I52 _bG68 2002
082	0	0	_a338.4'76151'0954 _bGOV
100	1		_aGovindaraj, Ramesh.
245	1	4	_aThe Indian pharmaceutical sector : _bissues and options for health sector reform /
260			_aWashington, D.C. : _bWorld Bank, _cc2002.
300			_axiii, 59 p. ;
440			_aWorld Bank discussion paper ; no. 437
504			_aIncludes bibliographical references: p. 48-59.
520			_aThis report on the pharmaceutical sector in India provides a systematic description and analysis of the profound gap that exists between the benefit that pharmaceuticals have to offer, and the reality that for millions of poor people in India medicines are still unaffordable, unsafe, and improperly used. It further outlines several strategic options that could strengthen India's ability to ensure the availability, affordability, quality and rational use of essential medicines on a sustainable basis, using an appropriate mix of public and private sector resources. Overall, the report represents an important and useful contribution to the literature on the role of pharmaceutical policy in delivering equitable, efficient, and high quality health care services to poor people in developing countries.
590			_ane 28/07/2021
591			_aLoans
650		0	_aPharmaceutical industry.
650		0	_aDrugs.
650		0	_aPharmaceutical policy.
651			_aIndia.
700	1		_aChellaraj, Gnanaraj.
710			_aThe International Bank for Reconstruction and Development/The World Bank.
942			_2ddc _cBOOK
949			_a338.4'76151'0954 GOV
999			_c4946 _d4946